• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
TAPS-tool reveals severe under detection of substance use problems in patients with severe mental illness.TAPS 工具揭示严重精神疾病患者物质使用问题的严重漏检情况。
PLoS One. 2024 Jul 24;19(7):e0305142. doi: 10.1371/journal.pone.0305142. eCollection 2024.
2
Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients.烟草、酒精、处方药及其他物质使用(TAPS)工具在初级保健患者物质使用筛查中的性能
Ann Intern Med. 2016 Nov 15;165(10):690-699. doi: 10.7326/M16-0317. Epub 2016 Sep 6.
3
Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care.验证 TAPS-1:一种用于在初级保健中识别不健康物质使用的四项筛查工具。
J Gen Intern Med. 2017 Sep;32(9):990-996. doi: 10.1007/s11606-017-4079-x. Epub 2017 May 26.
4
Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool.美国国家药物滥用研究所烟草、酒精、处方药及物质使用/滥用(TAPS)工具的临床试验网络验证研究设计
Contemp Clin Trials. 2016 Sep;50:90-7. doi: 10.1016/j.cct.2016.07.013. Epub 2016 Jul 19.
5
Identifying substance misuse in primary care: TAPS Tool compared to the WHO ASSIST.在初级保健中识别药物滥用:将TAPS工具与世界卫生组织ASSIST工具进行比较。
J Subst Abuse Treat. 2017 May;76:69-76. doi: 10.1016/j.jsat.2017.01.013. Epub 2017 Jan 31.
6
Validation of the tobacco, alcohol, prescription medication, and other substance use (TAPS) tool with the WHO alcohol, smoking, and substance Involvement screening test (ASSIST).验证烟草、酒精、处方药物和其他物质使用(TAPS)工具与世界卫生组织酒精、吸烟和物质使用筛查测试(ASSIST)的一致性。
Addict Behav. 2022 Mar;126:107178. doi: 10.1016/j.addbeh.2021.107178. Epub 2021 Nov 10.
7
Substance use disorders in individuals with body dysmorphic disorder.患有躯体变形障碍的个体的物质使用障碍
J Clin Psychiatry. 2005 Mar;66(3):309-16; quiz 404-5. doi: 10.4088/jcp.v66n0306.
8
Comorbid mental disorders in substance users from a single catchment area--a clinical study.物质使用者共病精神障碍的单流域临床研究。
BMC Psychiatry. 2011 Feb 12;11:25. doi: 10.1186/1471-244X-11-25.
9
Association of antisocial personality disorder and substance disorder morbidity in a clinical sample.临床样本中反社会人格障碍与物质使用障碍发病率的关联
Am J Drug Alcohol Abuse. 2005;31(1):93-110.
10
Prevalence and correlates of alcohol and other substance use disorders in young adulthood: A population-based study.青年期酒精及其他物质使用障碍的患病率及其相关因素:一项基于人群的研究。
BMC Psychiatry. 2009 Nov 19;9:73. doi: 10.1186/1471-244X-9-73.

本文引用的文献

1
Substance use outcomes among individuals with severe mental illnesses receiving assertive community treatment: A systematic review.接受积极社区治疗的严重精神疾病患者的物质使用结果:一项系统综述。
Int J Ment Health Nurs. 2023 Jun;32(3):704-726. doi: 10.1111/inm.13103. Epub 2022 Dec 19.
2
Severe Mental Illness and Cardiovascular Disease: JACC State-of-the-Art Review.严重精神疾病与心血管疾病:美国心脏病学会心脏病学实践中的前沿观点综述。
J Am Coll Cardiol. 2022 Aug 30;80(9):918-933. doi: 10.1016/j.jacc.2022.06.017.
3
Validation of the tobacco, alcohol, prescription medication, and other substance use (TAPS) tool with the WHO alcohol, smoking, and substance Involvement screening test (ASSIST).验证烟草、酒精、处方药物和其他物质使用(TAPS)工具与世界卫生组织酒精、吸烟和物质使用筛查测试(ASSIST)的一致性。
Addict Behav. 2022 Mar;126:107178. doi: 10.1016/j.addbeh.2021.107178. Epub 2021 Nov 10.
4
Epidemiology of Recovery From Alcohol Use Disorder.酒精使用障碍康复的流行病学。
Alcohol Res. 2020 Nov 12;40(3):02. doi: 10.35946/arcr.v40.3.02. eCollection 2020.
5
Development and Feasibility of a Spanish Language Version of the Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use (TAPS) Tool.开发及验证西班牙语版烟草、酒精、处方药物和非法物质使用评估工具(TAPS)。
J Addict Med. 2021;15(1):61-67. doi: 10.1097/ADM.0000000000000699.
6
Age of onset of substance use in patients with dual diagnosis and its association with clinical characteristics, risk behaviors, course, and outcome: A retrospective study.双重诊断患者物质使用的起始年龄及其与临床特征、风险行为、病程和结局的关联:一项回顾性研究。
Indian J Psychiatry. 2019;61(4):359-368. doi: 10.4103/psychiatry.IndianJPsychiatry_454_18.
7
Treatment of substance use disorders with co-occurring severe mental health disorders.治疗伴有严重精神健康障碍的物质使用障碍。
Curr Opin Psychiatry. 2019 Jul;32(4):293-299. doi: 10.1097/YCO.0000000000000510.
8
Mobile Intervention for Individuals With Psychosis, Dual Disorders, and Their Common Comorbidities: A Literature Review.针对患有精神病、双重障碍及其常见共病个体的移动干预:文献综述
Front Psychiatry. 2019 May 3;10:302. doi: 10.3389/fpsyt.2019.00302. eCollection 2019.
9
Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: Systematic review and meta-analysis.1990-2017 年社区和临床环境中精神分裂症谱系障碍共病物质使用的流行情况:系统评价和荟萃分析。
Drug Alcohol Depend. 2018 Oct 1;191:234-258. doi: 10.1016/j.drugalcdep.2018.07.011. Epub 2018 Aug 22.
10
Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care.验证 TAPS-1:一种用于在初级保健中识别不健康物质使用的四项筛查工具。
J Gen Intern Med. 2017 Sep;32(9):990-996. doi: 10.1007/s11606-017-4079-x. Epub 2017 May 26.

TAPS 工具揭示严重精神疾病患者物质使用问题的严重漏检情况。

TAPS-tool reveals severe under detection of substance use problems in patients with severe mental illness.

机构信息

GGZ Oost Brabant, Boekel, The Netherlands.

Behavioural Science Institute (BSI), Radboud University, Nijmegen, The Netherlands.

出版信息

PLoS One. 2024 Jul 24;19(7):e0305142. doi: 10.1371/journal.pone.0305142. eCollection 2024.

DOI:10.1371/journal.pone.0305142
PMID:39047031
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11268639/
Abstract

INTRODUCTION

Substance use disorders (SUD) and associated problems are highly prevalent but often undetected in patients with Severe Mental Illness (SMI). This study investigates the prevalence, under-detection, and variables associated with a high risk of SUD in a Dutch sample of adult outpatient SMI patients (N = 83).

METHODS

Substance use (The Tobacco, Alcohol, Prescription medication, and other Substance use -TAPS-tool), quality of life (Manchester Short Assessment of Quality of Life-MANSA), general functioning (Health of the Nation Outcome Scale-HoNOS), DSM-5 classifications and patient characteristics (age, education, marital status) were assessed. Detection of SUD was determined by calculating % agreement of DSM-5 classification to TAPS outcome. A logistic regression analysis was performed to determine the association of patient characteristics, quality of life and general functioning to an increased risk of SUD as determined by the TAPS.

RESULTS

Concerning prevalence, 89% of the patients used tobacco, above guideline-recommended daily limits of alcohol, illicit drugs or prescription medications for nonmedical purposes. Almost all smokers, half of the alcohol users and three-quarter of the patients that use marihuana or stimulant drugs had a high risk of SUD. All patients with high risk of SUD associated with alcohol, drugs or medications also had SUD associated with tobacco use. Concerning under detection less than half of the patients with a high risk of SUD according the TAPS had a SUD in their DSM-5 classification. Gender, partner, age and satisfaction about the relationship with family had a significant association with a high risk of SUD.

CONCLUSIONS

Screening for addiction in an SMI sample with the TAPS-tool revealed a high prevalence of substance use and a high risk of SUD. TAPS outcomes compared to the clinically obtained DSM-5 classification revealed a high degree of under-detection of substance use problems. Smoking seems to pose a specific additional risk of addiction and deserves more attention in treatment to achieve greater health care benefits.

摘要

简介

物质使用障碍(SUD)及其相关问题在患有严重精神疾病(SMI)的患者中非常普遍,但往往未被发现。本研究调查了荷兰成年门诊 SMI 患者(N=83)样本中 SUD 的患病率、漏诊率以及与 SUD 高风险相关的变量。

方法

使用物质使用(烟草、酒精、处方药物和其他物质使用-TAPS 工具)、生活质量(曼彻斯特短期生活质量评估-MANSA)、一般功能(国民健康结果量表-HoNOS)、DSM-5 分类和患者特征(年龄、教育程度、婚姻状况)进行评估。通过计算 DSM-5 分类与 TAPS 结果的%一致性来确定 SUD 的检出情况。进行逻辑回归分析,以确定患者特征、生活质量和一般功能与 TAPS 确定的 SUD 高风险的关联。

结果

关于患病率,89%的患者使用烟草,超过了酒精、非法药物或处方药物的每日建议限量,用于非医疗目的。几乎所有的吸烟者、一半的饮酒者和四分之三的使用大麻或兴奋剂药物的患者都有 SUD 的高风险。所有 TAPS 确定的与酒精、药物或药物相关的 SUD 高风险患者也与烟草使用相关的 SUD。关于漏诊,根据 TAPS,不到一半的 SUD 高风险患者在 DSM-5 分类中有 SUD。性别、伴侣、年龄和对家庭关系的满意度与 SUD 高风险有显著关联。

结论

使用 TAPS 工具对 SMI 样本进行成瘾筛查显示,物质使用的患病率很高,SUD 的风险很高。TAPS 结果与临床获得的 DSM-5 分类相比,显示出物质使用问题的漏诊程度很高。吸烟似乎构成了成瘾的特定附加风险,值得在治疗中给予更多关注,以实现更大的医疗保健效益。